Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity. - Chung, Jooho; Vallurupalli, Mounica; Noel, Sarah; Schor, Gail; Mrowka, Sofia; Scapozza, Ilario; Demere, Zelalem; Kammula, Sachin V.; Hu, Margaret; Kim, Sarah Y.; Liu, YuhJong; Nobrega, Celeste; et al. (Science, 2026)